1-5 of 5
Jens Pahl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Bispecific Innate Cell Engager AFM28 Can Leverage AML Patient's NK Cells in Addition to Allogeneic NK Cells, Enabling Elimination of CD123+ Leukemic Stem and Progenitor Cells in AML and MDS

Nanni Schmitt, Jana-Julia Siegler, Alexandra Beck, Lea Hoppe, Mohammed Abba, Alexander Streuer, Stefan Klein, Wolf-Karsten Hofmann, Christian Merz, Jens Pahl, Daniel Nowak
Journal: Blood
Blood (2024) 144 (Supplement 1): 4143.
https://doi.org/10.1182/blood-2024-210275
Published: 2024
Journal Articles

Cryopreserved CAR-like NK Cells Pre-Complexed with the CD30/CD16A Bispecific Innate Cell Engager (ICE®) AFM13 for the Treatment of CD30 + Malignancies

Uwe Reusch, Kristina Ellwanger, Ivica Fucek, Thomas Müller, Ute Schniegler-Mattox, Jens Pahl, Michael Tesar, Joachim Koch
Journal: Blood
Blood (2021) 138 (Supplement 1): 3992.
https://doi.org/10.1182/blood-2021-150552
Published: 2021
Journal Articles

AFM28, a Novel Bispecific Innate Cell Engager (ICE ® ), Designed to Selectively Re-Direct NK Cell Lysis to CD123+ Leukemic Cells in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Jana-Julia Götz, Jens Pahl, Nanni Schmitt, Thomas Müller, Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Stefan Knackmuss, Eike Peters, Uwe Reusch, Thorsten Ross, Daniel Nowak, Wolf-Karsten Hofmann, Christian Merz
Journal: Blood
Blood (2021) 138 (Supplement 1): 3344.
https://doi.org/10.1182/blood-2021-152463
Published: 2021
Journal Articles

CD16A-Specific Tetravalent Bispecific Immune Cell Engagers Potently Induce Antibody-Dependent Cellular Phagocytosis (ADCP) on Macrophages

Susanne Wingert, PhD, Uwe Reusch, PhD, Armin Beez, Jens Pahl, PhD, Adelheid Cerwenka, PhD, Joachim Koch, PhD, Martin Treder, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1111.
https://doi.org/10.1182/blood-2018-99-118427
Published: 2018
Journal Articles

AFM13 Is the Most Advanced Bispecific NK-Cell Engaging Antibody in Clinical Development Substantially Enhancing NK-Cell Effector Function and Proliferation

Jens Pahl, PhD, Uwe Reusch, PhD, Thorsten Gantke, PhD, Anne Kerber, MD, Joachim Koch, PhD, Martin Treder, PhD, Adelheid Cerwenka, PhD
Journal: Blood
Blood (2016) 128 (22): 1764.
https://doi.org/10.1182/blood.V128.22.1764.1764
Published: 2016